As the first innovative Contract Research Organization (CRO) in China, we are focuses on innovative strategies and design of innovative drugs for serious diseases such as cancer. We are dedicated to providing services for new drug research and development and other supporting services to global and Chinese pharmaceutical and biotechnology companies. We have extensive experience in the design, data management, statistical analysis, medicine, clinical pharmacology and pharmacovigilance of clinical trials. Our business involves chemical drugs, biological products and cell therapy, with in-depth research in pediatrics, rare diseases and bridging trials.

Available from the IND to NDA's whole process service: clinical trial design services; Medical affairs service; Data management services; Statistical analysis of service; Pharmacovigilance services, project management services; Register the transaction service; Quality management services.